BioStock invites you to watch ExpreS2ion Biotechnologies' company presentation today at 10:00. The company develops protein-based vaccines using its platform technology ExpreS2. Today, the pipeline consists of projects in four indications: covid-19, breast cancer, influenza and malaria. The company is currently carrying out a rights issue of
Watch CEO Bent U. Frandsen present the company at biostock.se:
https://www.biostock.se/2022/04/biostock-investor-pitch-expres2ion-biotechnologies/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
https://news.cision.com/expres2ion-biotechnologies/r/biostock-investor-pitch--expres2ion-biotechnologies,c3547844
(c) 2022 Cision. All rights reserved., source